Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Sanquin Research & Blood Bank Divisions Atrium Medical Center Maasland Hospital |
---|---|
Information provided by: | Sanquin Research & Blood Bank Divisions |
ClinicalTrials.gov Identifier: | NCT00202475 |
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood. The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon. Also, successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared.
Condition | Intervention | Phase |
---|---|---|
Pre Operative Autologous Donation |
Procedure: eythrocytapheresis Procedure: whole blood collection |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Collection of Autologous Blood Products by Double Erythrocytapheresis - Cost Effectiveness Study |
Enrollment: | 100 |
Study Start Date: | September 2003 |
Study Completion Date: | December 2007 |
Primary Completion Date: | September 2006 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator |
Procedure: eythrocytapheresis
machinal collection of erythrocytes
|
2: Active Comparator |
Procedure: whole blood collection
collection of whole blood
|
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood. The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon. Also, successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Netherlands | |
Sanquin Blood Bank Southeast Region | |
Maastricht, Netherlands, 6229 GR |
Principal Investigator: | Eva Rombout, MD | Sanquin Research and Blood Bank Divisions |
Responsible Party: | Sanquin Blood BankDivision South-east ( Dr. Wim de Kort PhD ) |
Study ID Numbers: | PPO-C-02-15 |
Study First Received: | September 13, 2005 |
Last Updated: | February 23, 2009 |
ClinicalTrials.gov Identifier: | NCT00202475 History of Changes |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Dubble eerythrocytapheresis |